CYTEIR THERAPEUTICS - Trademark Details
Status: 732 - Third Extension - Granted
Serial Number
88510194
Word Mark
CYTEIR THERAPEUTICS
Status
732 - Third Extension - Granted
Status Date
2021-09-08
Filing Date
2019-07-11
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
011525, 260111, 260121, 260131, 261701, 261704, 261705, 261706 - Other natural phenomena and observable events. Letters, numerals, punctuation, geometric figures, objects, humans, plants or animals comprising a circle. Circles that are totally or partially shaded. Five or more circles. Straight line(s), band(s) or bar(s). Vertical line(s), band(s) or bar(s). Horizontal line(s), band(s) or bar(s). Diagonal line(s), band(s) or bar(s).
Published for Opposition Date
2020-02-25
Attorney Name
Law Office Assigned Location Code
M50
Employee Name
MARTIN, EUGENIA K
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"THERAPEUTICS"
Description of Mark
The mark consists of a circular pattern of dots resembling a starburst design, and the words "CYTEIR THERAPEUTICS" stacked to the right of the design on two lines of black font text, with the text on the first line in slightly larger font.
Goods and Services
pharmaceutical preparations for treatment of cancer and autoimmune diseases; pharmaceutical preparations for use in oncology, hematology, and immunology; synthetic lethal therapies for inducing destruction of diseased cells with DNA damage for medical treatment purposes
Goods and Services
Research and development of medical tests for analyzing synthetic lethality and DNA damage; research and development of synthetic lethal therapies and biomarkers of synthetic lethality; medical laboratory services; medical testing for scientific research purposes in the field of oncology, synthetic lethality, and DNA repair; providing medical and scientific research information in the fields of synthetic lethality, DNA repair, synthetic lethal therapies, oncology, hematology, and immunology; drug discovery services
Goods and Services
Medical testing for diagnostic or treatment services; medical testing services for developing personalized therapies
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-07-18
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-07-18
Primary Code
044
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Karen Won
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Continuity Child | 88982019 |
Trademark Events
Event Date | Event Description |
2019-07-15 | NEW APPLICATION ENTERED IN TRAM |
2019-07-18 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-07-19 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2019-09-16 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
2019-09-23 | ASSIGNED TO LIE |
2019-09-25 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2019-09-26 | ASSIGNED TO EXAMINER |
2019-09-27 | NON-FINAL ACTION WRITTEN |
2019-09-27 | NON-FINAL ACTION E-MAILED |
2019-09-27 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-11-22 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2019-11-22 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2020-01-02 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-01-02 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-01-02 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-01-02 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2020-01-17 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-02-05 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-02-25 | PUBLISHED FOR OPPOSITION |
2020-02-25 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-04-21 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2020-09-18 | TEAS EXTENSION RECEIVED |
2020-09-18 | EXTENSION 1 FILED |
2020-09-18 | EXTENSION 1 GRANTED |
2020-09-22 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-03-01 | TEAS EXTENSION RECEIVED |
2021-03-01 | TEAS REQUEST TO DIVIDE RECEIVED |
2021-03-15 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2021-06-14 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2021-03-01 | DIVISIONAL REQUEST RECEIVED |
2021-06-15 | DIVISIONAL PROCESSING COMPLETE |
2021-03-01 | EXTENSION 2 FILED |
2021-06-15 | EXTENSION 2 GRANTED |
2021-06-16 | CORRECTED NOA E-MAILED |
2021-06-16 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-09-08 | TEAS EXTENSION RECEIVED |
2021-09-08 | EXTENSION 3 FILED |
2021-09-08 | EXTENSION 3 GRANTED |
2021-09-10 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |